Evidence supporting the use of: GABA (gamma aminobutyric acid)
For the health condition: Epilepsy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, playing a crucial role in reducing neuronal excitability throughout the nervous system. Epilepsy is characterized by abnormal, excessive neuronal activity, and one of the main mechanisms underlying many forms of epilepsy is an imbalance between excitatory and inhibitory neurotransmission, often involving a deficiency in GABAergic activity. Many anticonvulsant drugs used in the treatment of epilepsy, such as benzodiazepines and barbiturates, work by enhancing the effect of GABA at its receptors, thereby increasing inhibitory signaling and decreasing the likelihood of seizure activity.

However, direct supplementation with GABA itself has limited evidence for efficacy in treating epilepsy. GABA does not readily cross the blood-brain barrier when taken orally, so increasing peripheral GABA levels may not significantly affect brain GABA concentrations. Most of the scientific rationale for targeting GABA in epilepsy comes from the success of medications that modulate GABAergic function rather than from GABA supplementation itself. Clinical guidelines and systematic reviews do not support the routine use of oral GABA supplements for epilepsy. Therefore, while the role of GABAergic mechanisms in epilepsy is scientifically validated, the use of GABA supplements as a treatment for epilepsy is not strongly supported by clinical evidence.

In summary, GABA is central to the neurobiology of epilepsy, and many effective epilepsy drugs act on GABAergic pathways, but direct GABA supplementation is not a scientifically validated treatment for epilepsy.

More about GABA (gamma aminobutyric acid)
More about Epilepsy